J. Javier Diaz-Mejia

J. Javier Diaz-Mejia

Auto-generated profile, based on publicly available information

J. Javier Diaz-Mejia

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Nature
Verified
Journal Article
Closed access
PDF file
LHLiam Hendrikse
Liam Hendrikse
PHParthiv Haldipur
Parthiv Haldipur
OSOlivier Saulnier
Olivier Saulnier
JMJake Millman
Jake Millman
ASAlexandria H. Sjoboen
Alexandria H. Sjoboen
MTMichael D. Taylor
Michael D. Taylor

2 September 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
DCDavid G. Coffey
David G. Coffey
FMFrancesco Maura
Francesco Maura
EGEdgar Gonzalez-Kozlova
Edgar Gonzalez-Kozlova
JDJ. Javier Diaz-Mejia
J. Javier Diaz-Mejia
PLPing Luo
Ping Luo
OLOla Landgren
Ola Landgren
The role of the immune microenvironment in maintaining disease remission in patients with multiple myeloma (MM) is not well understood. In this study, we comprehensively profile the immune system in patients with newly diagnosed MM receiving continuous lenalidomide maintenance therapy with the aim of discovering correlates of long-term treatment response. Leveraging single-cell RNA sequencing and T cell receptor β sequencing of the peripheral blood and CyTOF mass cytometry of the bone marrow, we longitudinally characterize the immune landscape in 23 patients before and one year after lenalidomide exposure. We compare patients achieving sustained minimal residual disease (MRD) negativity to patients who never achieved or were unable to maintain MRD negativity. We observe that the composition of the immune microenvironment in both the blood and the marrow varied substantially according to both MRD negative status and history of autologous stem cell transplant, supporting the hypothesis that the immune microenvironment influences the depth and duration of treatment response.

15 March 2019 in F1000Research
Verified
Journal Article
Open access
PDF file
JDJ. Javier Diaz-Mejia
J. Javier Diaz-Mejia
EMElaine C. Meng
Elaine C. Meng
APAlexander R. Pico
Alexander R. Pico
SMSonya MacParland
Sonya MacParland
TKTroy Ketela
Troy Ketela
JMJohn H. Morris
John H. Morris
Background: Identification of cell type subpopulations from complex cell mixtures using single-cell RNA-sequencing (scRNA-seq) data includes automated computational steps like data normalization, dimensionality reduction and cell clustering. However, assigning cell type labels to cell clusters is still conducted manually by most researchers, resulting in limited documentation, low reproducibility and uncontrolled vocabularies. Two bottlenecks to automating this task are the scarcity of reference cell type gene expression signatures and the fact that some dedicated methods are available only as web servers with limited cell type gene expression signatures. Methods: In this study, we benchmarked four methods (CIBERSORT, GSEA, GSVA, and ORA) for the task of assigning cell type labels to cell clusters from scRNA-seq data. We used scRNA-seq datasets from liver, peripheral blood mononuclear cells and retinal neurons for which reference cell type gene expression signatures were available. Results: Our results show that, in general, all four methods show a high performance in the task as evaluated by receiver operating characteristic curve analysis (average area under the curve (AUC) = 0.94, sd = 0.036), whereas precision-recall curve analyses show a wide variation depending on the method and dataset (average AUC = 0.53, sd = 0.24). Conclusions: CIBERSORT and GSVA were the top two performers. Additionally, GSVA was the fastest of the four methods and was more robust in cell type gene expression signature subsampling simulations. We provide an extensible framework to evaluate other methods and datasets at https://github.com/jdime/scRNAseq_cell_cluster_labeling.

14 October 2019 in F1000Research
Verified
Journal Article
Open access
PDF file
JDJ. Javier Diaz-Mejia
J. Javier Diaz-Mejia
EMElaine C. Meng
Elaine C. Meng
APAlexander R. Pico
Alexander R. Pico
SMSonya MacParland
Sonya MacParland
TKTroy Ketela
Troy Ketela
JMJohn H. Morris
John H. Morris
Background: Identification of cell type subpopulations from complex cell mixtures using single-cell RNA-sequencing (scRNA-seq) data includes automated steps from normalization to cell clustering. However, assigning cell type labels to cell clusters is often conducted manually, resulting in limited documentation, low reproducibility and uncontrolled vocabularies. This is partially due to the scarcity of reference cell type signatures and because some methods support limited cell type signatures. Methods: In this study, we benchmarked five methods representing first-generation enrichment analysis (ORA), second-generation approaches (GSEA and GSVA), machine learning tools (CIBERSORT) and network-based neighbor voting (METANEIGHBOR), for the task of assigning cell type labels to cell clusters from scRNA-seq data. We used five scRNA-seq datasets: human liver, 11 Tabula Muris mouse tissues, two human peripheral blood mononuclear cell datasets, and mouse retinal neurons, for which reference cell type signatures were available. The datasets span Drop-seq, 10X Chromium and Seq-Well technologies and range in size from ~3,700 to ~68,000 cells. Results: Our results show that, in general, all five methods perform well in the task as evaluated by receiver operating characteristic curve analysis (average area under the curve (AUC) = 0.91, sd = 0.06), whereas precision-recall analyses show a wide variation depending on the method and dataset (average AUC = 0.53, sd = 0.24). We observed an influence of the number of genes in cell type signatures on performance, with smaller signatures leading more frequently to incorrect results. Conclusions: GSVA was the overall top performer and was more robust in cell type signature subsampling simulations, although different methods performed well using different datasets. METANEIGHBOR and GSVA were the fastest methods. CIBERSORT and METANEIGHBOR were more influenced than the other methods by analyses including only expected cell types. We provide an extensible framework that can be used to evaluate other methods and datasets at https://github.com/jdime/scRNAseq_cell_cluster_labeling .

22 July 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
MRMiriam S. Reuter
Miriam S. Reuter
DSDustin J. Sokolowski
Dustin J. Sokolowski
JDJ. Javier Diaz-Mejia
J. Javier Diaz-Mejia
JKJohannes Keunen
Johannes Keunen
BVBarbra de Vrijer
Barbra de Vrijer
RCRajiv R. Chaturvedi
Rajiv R. Chaturvedi
Low blood flow through the fetal left heart is often conjectured as an etiology for hypoplastic left heart syndrome (HLHS). To investigate if a decrease in left heart flow results in growth failure, we generate left ventricular inflow obstruction (LVIO) in mid-gestation fetal lambs by implanting coils in their left atrium using an ultrasound-guided percutaneous technique. Significant LVIO recapitulates important clinical features of HLHS: decreased antegrade aortic valve flow, compensatory retrograde perfusion of the brain and ascending aorta (AAo) from the arterial duct, severe left heart hypoplasia, a non-apex forming LV, and a thickened endocardial layer. The hypoplastic AAo have miRNA-gene pairs annotating to cell proliferation that are inversely differentially expressed by bulk RNA-seq. Single-nucleus RNA-seq of the hypoplastic LV myocardium shows an increase in fibroblasts with a reciprocal decrease in cardiomyocyte nuclei proportions. Fibroblasts, cardiomyocytes and endothelial cells from hypoplastic myocardium have increased expression of extracellular matrix component or fibrosis genes with dysregulated fibroblast growth factor signaling. Hence, a severe sustained ( ~ 1/3 gestation) reduction in fetal left heart flow is sufficient to cause left heart hypoplasia. This is accompanied by changes in cellular composition and gene expression consistent with a pro-fibrotic environment and aberrant induction of mesenchymal programs.

6 August 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
LRLaura M. Richards
Laura M. Richards
MRMazdak Riverin
Mazdak Riverin
SMSuluxan Mohanraj
Suluxan Mohanraj
SAShamini Ayyadhury
Shamini Ayyadhury
DCDanielle C. Croucher
Danielle C. Croucher
TPTrevor J Pugh
Trevor J Pugh
Tumours are routinely profiled with single-cell RNA sequencing (scRNA-seq) to characterize their diverse cellular ecosystems of malignant, immune, and stromal cell types. When combining data from multiple samples or studies, batch-specific technical variation can confound biological signals. However, scRNA-seq batch integration methods are often not designed for, or benchmarked, on datasets containing cancer cells. Here, we compare 5 data integration tools applied to 171,206 cells from 5 tumour scRNA-seq datasets. Based on our results, STACAS and fastMNN are the most suitable methods for integrating tumour datasets, demonstrating robust batch effect correction while preserving relevant biological variability in the malignant compartment. This comparison provides a framework for evaluating how well single-cell integration methods correct for technical variability while preserving biological heterogeneity of malignant and non-malignant cell populations.